Home › Juvenile Arthritis › New York
Juvenile Arthritis clinical trials in New York
5 studies for Juvenile Arthritis are looking for participants at sites in New York.
Cities in New York
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Col Uni Med Center New York Presby, New York
RecruitingPhase 1
Ages 2 to 17 · All sexes · Updated Sep 28, 2026 · NCT06751238Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Boston Childrens Health Physicians /ID# 253437, Valhalla
RecruitingPhase 3
Ages 1 to 17 · All sexes · Updated Sep 15, 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Columbia University Medical Center /ID# 262587, New York
- Boston Childrens Health Physicians /ID# 258061, Valhalla
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Albany Medical College, Albany
- Cohen Children's Medical Center of New York, Lake Success
- Hospital for Special Surgery, New York
- and 3 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.